MIM
TDOC icon

MetLife Investment Management’s Teladoc Health TDOC Stock Holding History

MetLife Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$902K Buy
106,338
+16,322
+18% +$109K ﹤0.01% 1576
2026
Q1 		$491K Sell
90,016
-3,784
-4% -$21.2K ﹤0.01% 1759
2025
Q4 		$657K Sell
93,800
-1,862
-2% -$14.6K ﹤0.01% 1665
2025
Q3 		$739K Sell
95,662
-6,162
-6% -$48.1K ﹤0.01% 1616
2025
Q2 		$887K Hold
101,824
– – 0.01% 1372
2025
Q1 		$811K Buy
101,824
+212
+0.2% +$2.15K ﹤0.01% 1465
2024
Q4 		$924K Buy
101,612
+3,108
+3% +$30K 0.01% 1456
2024
Q3 		$904K Buy
98,504
+55,503
+129% +$459K 0.01% 1447
2024
Q2 		$421K Buy
43,001
+39,786
+1,238% +$485K ﹤0.01% 1821
2024
Q1 		$48.5K Buy
3,215
+7
+0.2% +$127 ﹤0.01% 2720
2023
Q4 		$69.1K Sell
3,208
-23
-0.7% -$424 ﹤0.01% 2737
2023
Q3 		$60.1K Buy
3,231
+5
+0.2% +$117 ﹤0.01% 2802
2023
Q2 		$81.7K Sell
3,226
-714
-18% -$18K ﹤0.01% 2799
2023
Q1 		$102K Buy
3,940
+9
+0.2% +$241 ﹤0.01% 2545
2022
Q4 		$93K Sell
3,931
-10
-0.3% -$270 ﹤0.01% 2621
2022
Q3 		$99.9K Sell
3,941
-72
-2% -$2.53K ﹤0.01% 2681
2022
Q2 		$133K Buy
4,013
+992
+33% +$42.1K ﹤0.01% 2570
2022
Q1 		$218K Buy
+3,021
New +$218K ﹤0.01% 2309
2020
Q2 		– Sell
-30,482
Closed -$4.73M – 2351
2020
Q1 		$4.73M Hold
30,482
– – 0.06% 272
2019
Q4 		$2.55M Hold
30,482
– – 0.03% 711
2019
Q3 		$2.06M Sell
30,482
-1,368
-4% -$90K 0.02% 778
2019
Q2 		$2.12M Sell
31,850
-55,318
-63% -$3.22M 0.02% 789
2019
Q1 		$4.85M Buy
87,168
+58,112
+200% +$3.55M 0.01% 880
2018
Q4 		$1.44M Hold
29,056
– – 0.02% 896
2018
Q3 		$2.51M Buy
29,056
+673
+2% +$48K 0.03% 768
2018
Q2 		$1.65M Buy
28,383
+3,032
+12% +$148K 0.02% 854
2018
Q1 		$1.02M Hold
25,351
– – 0.01% 997
2017
Q4 		$883K Buy
+25,351
New +$842K 0.01% 1079

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

MetLife Investment Management's TDOC Position: Q2 2026 in Review

MetLife Investment Management increased its Teladoc Health (TDOC) stake by 18% in Q2 2026, buying an estimated $109K and bringing the position to 106,338 shares worth $902K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

MetLife Investment Management first reported a position in TDOC in Q4 2017 and has held it in 28 quarters since. The position peaked at $4.85M in Q1 2019. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • MetLife Investment Management held 106,338 shares of Teladoc Health worth $902K as of Q2 2026.
  • MetLife Investment Management bought 16,322 Teladoc Health shares in Q2 2026, an estimated $109K.
  • Teladoc Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1576 holding.
  • MetLife Investment Management first reported a position in Teladoc Health in Q4 2017 and has held it in 28 quarters since.
  • MetLife Investment Management's Teladoc Health position peaked at $4.85M in Q1 2019.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.